This book describes various aspects of current scientific interest in clinical developments and management of pulmonary pathologies. Non-communicable and communicable disorders are tackled. Chronic disorders of an inflammatory background, such as COPD and asthma, often overlapping, diagnostically and therapeutically misguided and always difficult to manage, are in focus due to an increasing prevalence across the age range. The authors dwell on the disease management, exacerbations, care and therapy, taking into account all too often overlooked psychosomatic determinants. Novel markers of pulmonary sarcoidosis, also an inflammatory disease, albeit of unknown etiology, are described. The outstanding lung images of cystic fibrosis are presented in another chapter. Finally, there are reports on the extent of the influenza scourge in Poland during the past 2016/2017 epidemic season. The book is addressed to clinicians, family physicians, medical scholars, and all professionals engaged in the preservation of respiratory health.

Explores ongoing medical innovations Deals with practical aspects of disease management Provides outstanding compendium of clinical knowledge

Inhalt

Preface.- Coexistence of Chronic Bronchitis in Chronic Obstructive Lung Disease. -Influence of Gaseous Pollutants on COPD Exacerbations in Patients with Cardiovascular Comorbidities.- Chemotherapy-Induced Takotsubo Syndrome .- Blood Group and Incidence of Asthma and Chronic Obstructive Pulmonary Disease.- Satisfaction with Life and Adaptive Reactions in People Treated for Chronic Obstructive Pulmonary Disease.- Estimates of Medication Expenditure for Ischemic Heart Disease Accompanying Chronic Obstructive Pulmonary Disease.- Proangiogenic and Profibrotic Markers in Pulmonary Sarcoidosis.- Congruence between Pulmonary Function and Computed Tomography Imaging Assessment of Cystic Fibrosis Severity.- Detection of Influenza in the Epidemic Season 2016/2017 Based on IMOVE+ Project.- Influenza and Influenza-Like Viruses: Frequent Infections in Children under 14 Years of Age during the 2016/2017 Epidemic Season.- Index.